Literature DB >> 11069732

Modulation of human chondrocyte metabolism by recombinant human interferon.

Y E Henrotin1, S X Zheng, A H Labasse, G P Deby, J M Crielaard, J Y Reginster.   

Abstract

OBJECTIVES: Interferon gamma (IFN gamma) is found to be elevated in the synovial fluid of patients with rheumatoid arthritis and osteoarthritis, suggesting its implication in joint disease pathogenesis. In this study, we investigated the effects of IFN gamma on the production of cytokines (IL-6, IL-8, IL-10), prostaglandin E(2)(PGE(2)), proteoglycans (PG), nitric oxide (NO), interleukin-1 receptor antagonist (IL-1ra) and stromelysin by non-stimulated and IL-1 beta-treated human chondrocytes. The role played by NO in the responses of chondrocytes to IFN gamma was also examined by incubation of chondrocytes with N(G)-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of NO synthase.
METHODS: Enzymatically isolated human chondrocytes were cultured for 48 h in the absence or presence of IL-1 beta, IFN gamma or N(G)-monomethyl-L-arginine (L-NMMA) added solely or in combination. The productions of IL-6, IL-8, IL-10, IL-1ra and stromelysin were measured by enzyme amplified sensitivity immunoassays (EASIA). PG and PGE(2)were quantified by specific radioimmunoassays (RIA). Nitrite concentrations in the culture supernatants were determined by a spectrophotometric method based upon the Griess reaction.
RESULTS: As expected, IL-1 beta highly stimulated NO, IL-6, IL-8, IL-10, IL-1ra, PGE(2)and stromelysin synthesis, but dramatically decreased PG production. NO, IL-6, IL-1ra and PGE(2)production by non-stimulated chondrocytes was dose-dependently increased by IFN gamma while PG production was inhibited. In the absence of IL-1 beta, IL-10 was undetectable in the culture supernatants. At the doses of 10 and 100 U/ml, IFN gamma markedly inhibited the constitutive and IL-1 beta-stimulated IL-8, IL-10 and stromelysin productions. Interestingly, IFN gamma synergized with IL-1 beta to increase NO, IL-6, IL-1ra and to depress PG production. As previously reported, the inhibition of NO synthesis by the competitive inhibitor L-NMMA led to enhancement of IL-6, IL-8 and PGE(2)production by IL-1 beta treated chondrocytes, but did not significantly modify IL-10, PG and MMP-3 productions. Inhibition of NO synthase significantly inhibited the stimulating effect of IFN gamma on IL-6 and IL-1ra but did not affect the inhibitory effect of IFN gamma on IL-8, PG or stromelysin production.
CONCLUSIONS: These findings suggest that IFN gamma and IL-1 synergistically stimulate the production of IL-6, IL-1ra, NO and PGE(2)and inhibit PG synthesis. By contrast, IL-1 beta and IFN gamma have opposite effects on IL-8, IL-10 and stromelysin productions. These effects are not reversed by L-NMMA, suggesting that NO is not the principal mediator involved in responses of chondrocytes to IFN gamma. Copyright 2000 OsteoArthritis Research Society International.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069732     DOI: 10.1053/joca.1999.0323

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  9 in total

1.  Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma.

Authors:  R Ahmad; H Y Qureshi; M El Mabrouk; J Sylvester; M Ahmad; M Zafarullah
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

2.  Characterization of promoter elements of the human HYAL-2 gene.

Authors:  Geraldine Chow; Warren Knudson
Journal:  J Biol Chem       Date:  2005-05-27       Impact factor: 5.157

3.  Synovial fluid and peripheral blood immune complexes of patients with rheumatoid arthritis induce apoptosis in cytokine-activated chondrocytes.

Authors:  A J Schuerwegh; E J Dombrecht; W J Stevens; J F Van Offel; M M Kockx; C H Bridts; L S De Clerck
Journal:  Rheumatol Int       Date:  2007-04-03       Impact factor: 2.631

4.  Interferon-gamma inhibits interleukin-1beta-induced matrix metalloproteinase production by synovial fibroblasts and protects articular cartilage in early arthritis.

Authors:  Charlotte E Page; Shaun Smale; Sara M Carty; Nicholas Amos; Sarah N Lauder; Rhian M Goodfellow; Peter J Richards; Simon A Jones; Nicholas Topley; Anwen S Williams
Journal:  Arthritis Res Ther       Date:  2010-03-22       Impact factor: 5.156

5.  Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection.

Authors:  Marijn Rutgers; Daniël B F Saris; Wouter J A Dhert; Laura B Creemers
Journal:  Arthritis Res Ther       Date:  2010-06-10       Impact factor: 5.156

6.  FcgammaRI up-regulation induced by local adenoviral-mediated interferon-gamma production aggravates chondrocyte death during immune complex-mediated arthritis.

Authors:  Karin C Nabbe; Peter L van Lent; Astrid E Holthuysen; Jay K Kolls; Sjef Verbeek; Wim B van den Berg
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

Review 7.  Medical ozone therapy as a potential treatment modality for regeneration of damaged articular cartilage in osteoarthritis.

Authors:  Sello Lebohang Manoto; Makwese Johaness Maepa; Shirley Keolebogile Motaung
Journal:  Saudi J Biol Sci       Date:  2016-02-09       Impact factor: 4.219

8.  Excavating bioactivities of nanozyme to remodel microenvironment for protecting chondrocytes and delaying osteoarthritis.

Authors:  Weiduo Hou; Chenyi Ye; Mo Chen; Wei Gao; Xue Xie; Jianrong Wu; Kai Zhang; Wei Zhang; Yuanyi Zheng; Xiaojun Cai
Journal:  Bioact Mater       Date:  2021-01-29

9.  Interferon-gamma modulates articular chondrocyte and osteoblast metabolism through protein kinase R-independent and dependent mechanisms.

Authors:  S J Gilbert; E J Blain; D J Mason
Journal:  Biochem Biophys Rep       Date:  2022-09-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.